Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Balance versus preservative-free saline in lipid-deficient dry eye
NL-OMON38494Phase 4Active, not recruiting
- Sponsor
- Alcon Inc.
- Start
- Apr 2014
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Systane Balance and sodium chloride in dry eye syndrome (DED) and meibomian gland dysfunction (MGD) (2 arms), sponsored by Alcon Inc. Primary endpoint: Change from baseline in tear film break-up time. Started Apr 2014; status: active, not recruiting.
02
Drugs
Systane Balancesodium chloride
03
Conditions
dry eye syndrome (DED)meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NL-OMON38494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38494.